Replacing the failing tooth with a dental implant by Dr. John Tsourounakis

Tooth #13 (#6) presents in a cross-bite position

Depp probing depths were noted along with class III mobility.

A CBCT Scan confirmed the clinical findings and rendered a hopeless prognosis for the tooth

Upon extraction and flap reflection a fenestration was noted at the apical aspect of the buccal plate.

Complete loss of the palatal plate was noted

The site was augmented with a combination of Freeze-Dried bone allograft and bovine xenograft. An absorbable collagen membrane (Bio-gide) was used to cover the buccal fenestration, and a non-absorbable d-PTFE Ti reinforced membrane was used to resemble the missing palatal wall.

The buccal flap was advanced to cover the membrane, however, primary closure was not achieved.

Exposure of the membrane was noted after two weeks of healing.

No signs of infection were noted and the membrane was removed 8 weeks following the augmentation of the deficient site.

Complete epithelialization of the site was noted 2 weeks after the membrane was removed

Complete reconstruction of the ridge was noted 4 months following the augmentation procedure.

A CBCT Scan revealed adequate bone volume for implant placement

Clinical measurement revealed a 7-8mm wide ridge with no vertical deficiency

An Astra, Osseospeed EV implant, 4.2x9.0mm was placed, with insertion torque of >35N/cm

The healing was uneventful

A screw retained restoration was placed

Prosthetics by Dr Ernest Cholakis. Ceramics by Mr. John Verogos, Alpha Ceramics

Replacing the failing tooth with a dental implant

by John Tsourounakis DDS, MS, FRCDC, Diplomate of the American Board of Periodontology

JohnT.perio@gmail.com

Southwest Specialty Group, Winnipeg, Manitoba

Created By
John Tsourounakis
Appreciate

Made with Adobe Slate

Make your words and images move.

Get Slate

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.